Home

asdasd22d
Title: Slide 2
Title Credit Type Therapeutic Area Format
Novel Medications for the Treatment of NHL: A Closer Look at Anti-CD30 Antibodies, EZH2 Inhibitors, and PI3K Inhibitors CPE Hematology, Oncology On-Demand Webcast
Formulary Perspectives in Myelodysplastic Syndromes and Acute Myeloid Leukemia: Novel Treatment Options for High-Risk Subtypes CPE Hematology, Oncology On-Demand Webcast
Venous Stenting in Non-Thrombotic Venous Patients AANP, ARRT, CME, CNE Radiology, Vascular On-Demand Webcast
PI3K Inhibitors in the Treatment of Non-Hodgkin Lymphomas AANP, CME, CNE, CPE Hematology, Oncology On-Demand Webcast
Clinical Updates in Mantle Cell Lymphoma: Emerging Therapies and Evolving Treatment Strategies AANP, CME, CNE, CPE Hematology, Oncology On-Demand Webcast
PI3K and EZH2 Inhibitors in the Treatment of Non-Hodgkin Lymphomas AANP, CME, CNE, CPE Hematology, Oncology On-Demand Webcast
COVID-19 Update: Adapting Management Strategies and Vaccine Recommendations AANP, CME, CNE, CPE Hematology, Oncology On-Demand Webcast
Novel Therapeutic Targets in Advanced Classic Hodgkin Lymphoma: Present and Future Challenges AANP, CME, CNE, CPE Hematology, Oncology On-Demand Webcast
TKIs in the Treatment of Ph+ CML: Achieving Optimal Outcomes AANP, CME, CNE, CPE Hematology, Oncology On-Demand Webcast
Advances in the Treatment of ALL in Adults: Treatment Approaches for Ph Positivity AANP, CME, CNE, CPE Hematology, Oncology On-Demand Webcast
Advances in R/R Multiple Myeloma: Overcoming Treatment Resistance with Novel Targets AANP, CME, CNE, CPE Hematology, Oncology On-Demand Webcast
Adverse Effects of Targeted Agents: Identification and Management Strategies for Patients with B-Cell Malignancies AANP, CME, CNE, CPE Hematology, Oncology On-Demand Webcast

Pages